Inflammation. Inflammations . A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. . 1.00
Anesthesia. A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. . 0.41
Posterior Cervical Sympathetic Syndrome. Syndrome of Barre-Lieou . Barre Lieou Syndrome . Syndrome of Barre Lieou . Syndrome, Barre-Lieou . Barre-Lieou Syndrome . A pathological condition that is characterized by a host of cranial symptoms, such as headaches, abnormal functions of the eyes and the ears, and psychological and mental disorders. This syndrome usually appears after neck injuries, inflammation, or neoplasm. . 0.38
Neurotoxicity Syndromes. Encephalopathy, Toxic . Nervous System Poisoning . Neurotoxic Disorders . Neurotoxin Diseases . Neurotoxin Disorders . Toxic Encephalitis . Encephalitides, Toxic . Encephalitis, Toxic . Encephalopathies, Toxic . Nervous System Poisonings . Neurotoxic Disorder . Neurotoxicity Syndrome . Neurotoxin Disease . Neurotoxin Disorder . Poisonings, Nervous System . Syndrome, Neurotoxicity . Syndromes, Neurotoxicity . Toxic Encephalitides . Toxic Encephalopathies . Toxic Encephalopathy . Poisoning, Nervous System . Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents. . 0.37
Fuchs' Endothelial Dystrophy. Fuch's Endothelial Dystrophy . Fuchs Atrophy . Fuchs Corneal Dystrophy . Fuchs Dystrophy . Fuchs Endothelial Corneal Dystrophy . Fuchs Endothelial Dystrophy . Dystrophy, Fuch's Endothelial . Dystrophy, Fuchs' Endothelial . Endothelial Dystrophy, Fuch's . Endothelial Dystrophy, Fuchs' . Fuch Endothelial Dystrophy . Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain. . 0.36
Quantitative Structure-Activity Relationship. 3D-QSAR . QSAR 23179 . QSPR Modeling . Quantitative Structure Property Relationship . 3D QSAR . 3D-QSARs . Modeling, QSPR . Quantitative Structure Activity Relationship . Quantitative Structure-Activity Relationships . Relationship, Quantitative Structure-Activity . Relationships, Quantitative Structure-Activity . Structure-Activity Relationship, Quantitative . Structure-Activity Relationships, Quantitative . Structure Activity Relationship, Quantitative . A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. . 0.36
Sporotrichosis. Sporothrix schenckii Infection . Infection, Sporothrix schenckii . Infections, Sporothrix schenckii . Sporothrix schenckii Infections . Sporotrichoses . The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX. . 0.36
Hypophysectomy, Chemical. Chemical Hypophysectomy . Chemical Hypophysectomies . Hypophysectomies, Chemical . Total or subtotal destruction of the pituitary gland by chemical injection. It is usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. It is usually performed for the treatment of intractable pain. . 0.35
Wasting Syndrome. Wasting Diseases . Wasting Syndromes . Wasting Disease . A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism. . 0.34
